Greenleaf Trust Eli Lilly & CO Transaction History

Greenleaf Trust

$11.2 Billion
Q3 2024

A detailed history of Greenleaf Trust transactions in Eli Lilly & CO stock. As of the latest transaction made, Greenleaf Trust holds 28,437 shares of LLY stock, worth $22.1 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

28,437

Previous 27,932 1.81%

Holding current value

$22.1 Million

Previous $25.3 Million 0.38%

% of portfolio

0.23%

Previous 0.24%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$772.14 - $960.02 $389,930 - $484,810	505 Added 1.81%	28,437 $25.2 Million
Q2 2024 Jul 22, 2024	BUY	$724.87 - $909.04 $1.35 Million - $1.7 Million	1,868 Added 7.17%	27,932 $25.3 Million
Q1 2024 Apr 29, 2024	SELL	$592.2 - $792.28 $1.76 Million - $2.35 Million	-2,970 Reduced 10.23%	26,064 $20.3 Million
Q4 2023 Jan 31, 2024	BUY	$525.19 - $619.13 $2.74 Million - $3.23 Million	5,210 Added 21.87%	29,034 $16.9 Million
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $37,384 - $51,539	86 Added 0.36%	23,824 $12.8 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $400,895 - $536,044	-1,143 Reduced 4.59%	23,738 $11.1 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $25,471 - $29,915	82 Added 0.33%	24,881 $8.54 Million
Q4 2022 Jan 25, 2023	SELL	$321.55 - $374.67 $13.9 Million - $16.2 Million	-43,274 Reduced 63.57%	24,799 $9.07 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $13.4 Million - $15.3 Million	45,191 Added 197.5%	68,073 $22 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $369,595 - $433,960	1,326 Added 6.15%	22,882 $7.42 Million
Q1 2022 Apr 27, 2022	BUY	$234.69 - $291.66 $226,710 - $281,743	966 Added 4.69%	21,556 $6.17 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $299,500 - $371,681	1,332 Added 6.92%	20,590 $5.69 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $51,189 - $62,996	231 Added 1.21%	19,258 $4.45 Million
Q2 2021 Aug 10, 2021	BUY	$180.55 - $233.54 $46,401 - $60,019	257 Added 1.37%	19,027 $4.37 Million
Q1 2021 Apr 30, 2021	BUY	$164.32 - $212.72 $316,316 - $409,486	1,925 Added 11.43%	18,770 $3.51 Million
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $186,949 - $247,378	1,433 Added 9.3%	16,845 $2.84 Million
Q3 2020 Oct 30, 2020	SELL	$146.22 - $169.13 $135,692 - $156,952	-928 Reduced 5.68%	15,412 $2.28 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $327,271 - $393,867	2,399 Added 17.21%	16,340 $2.68 Million
Q1 2020 Apr 29, 2020	BUY	$119.05 - $147.35 $224,171 - $277,460	1,883 Added 15.62%	13,941 $1.93 Million
Q4 2019 Feb 11, 2020	BUY	$106.92 - $132.43 $36,673 - $45,423	343 Added 2.93%	12,058 $1.59 Million
Q3 2019 Nov 08, 2019	SELL	$106.79 - $116.16 $2,135 - $2,323	-20 Reduced 0.17%	11,715 $1.31 Million
Q2 2019 Jul 24, 2019	SELL	$110.79 - $129.32 $23,819 - $27,803	-215 Reduced 1.8%	11,735 $1.3 Million
Q1 2019 May 08, 2019	BUY	$111.31 - $131.02 $60,997 - $71,798	548 Added 4.81%	11,950 $1.55 Million
Q4 2018 Feb 07, 2019	BUY	$105.9 - $118.64 $51,149 - $57,303	483 Added 4.42%	11,402 $1.32 Million
Q3 2018 Oct 29, 2018	BUY	$85.86 - $107.31 $94,789 - $118,470	1,104 Added 11.25%	10,919 $1.17 Million
Q2 2018 Aug 07, 2018	BUY	$75.7 - $86.88 $203,330 - $233,359	2,686 Added 37.68%	9,815 $838,000
Q1 2018 Apr 30, 2018	SELL	$74.21 - $87.6 $8,830 - $10,424	-119 Reduced 1.64%	7,129 $552,000
Q4 2017 Feb 08, 2018	BUY	$81.94 - $87.89 $90,297 - $96,854	1,102 Added 17.93%	7,248 $612,000
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $473,672 - $525,728	6,146	6,146 $526,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.

Account